These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 26232702)

  • 41. Self-assembly of oxidation-responsive polyethylene glycol-paclitaxel prodrug for cancer chemotherapy.
    Dong C; Zhou Q; Xiang J; Liu F; Zhou Z; Shen Y
    J Control Release; 2020 May; 321():529-539. PubMed ID: 32109513
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.
    Gong C; Xie Y; Wu Q; Wang Y; Deng S; Xiong D; Liu L; Xiang M; Qian Z; Wei Y
    Nanoscale; 2012 Sep; 4(19):6004-17. PubMed ID: 22910790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy.
    Han J; Michel AR; Lee HS; Kalscheuer S; Wohl A; Hoye TR; McCormick AV; Panyam J; Macosko CW
    Mol Pharm; 2015 Dec; 12(12):4329-35. PubMed ID: 26505116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Zein-Paclitaxel Prodrug Nanoparticles for Redox-Triggered Drug Delivery and Enhanced Therapeutic Efficiency.
    Hou H; Zhang D; Lin J; Zhang Y; Li C; Wang Z; Ren J; Yao M; Wong KH; Wang Y
    J Agric Food Chem; 2018 Nov; 66(44):11812-11822. PubMed ID: 30339011
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved anti-tumor activity and safety profile of a paclitaxel-loaded glycyrrhetinic acid-graft-hyaluronic acid conjugate as a synergistically targeted drug delivery system.
    Zhang L; Zhou JP; Yao J
    Chin J Nat Med; 2015 Dec; 13(12):915-24. PubMed ID: 26721710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Self-Assembly of pH-Labile Polymer Nanoparticles for Paclitaxel Prodrug Delivery: Formulation, Characterization, and Evaluation.
    Levit SL; Gade NR; Roper TD; Yang H; Tang C
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy.
    Shan L; Zhuo X; Zhang F; Dai Y; Zhu G; Yung BC; Fan W; Zhai K; Jacobson O; Kiesewetter DO; Ma Y; Gao G; Chen X
    Theranostics; 2018; 8(7):2018-2030. PubMed ID: 29556370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.
    Zhang L; Yao J; Zhou J; Wang T; Zhang Q
    Int J Pharm; 2013 Jan; 441(1-2):654-64. PubMed ID: 23117024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance.
    Wang L; Jia E
    Drug Deliv; 2016 Jun; 23(5):1810-7. PubMed ID: 26530693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.
    Lv S; Tang Z; Zhang D; Song W; Li M; Lin J; Liu H; Chen X
    J Control Release; 2014 Nov; 194():220-7. PubMed ID: 25220162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Calcium Phosphate-Reinforced Reduction-Sensitive Hyaluronic Acid Micelles for Delivering Paclitaxel in Cancer Therapy.
    Deng B; Xia M; Qian J; Li R; Li L; Shen J; Li G; Xie Y
    Mol Pharm; 2017 Jun; 14(6):1938-1949. PubMed ID: 28481545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Shell-crosslinked hybrid nanoparticles for direct cytosolic delivery for tumor therapy.
    He W; Jin Z; Lv Y; Cao H; Yao J; Zhou J; Yin L
    Int J Pharm; 2015 Jan; 478(2):762-72. PubMed ID: 25529435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced cytotoxicity of a redox-sensitive hyaluronic acid-based nanomedicine toward different oncocytes via various internalization mechanisms.
    Du Y; Wang S; Zhang T; He D; Tu J; Shen Y
    Drug Deliv; 2020 Dec; 27(1):128-136. PubMed ID: 31894722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficient simultaneous tumor targeting delivery of all-trans retinoid acid and Paclitaxel based on hyaluronic acid-based multifunctional nanocarrier.
    Yao J; Zhang L; Zhou J; Liu H; Zhang Q
    Mol Pharm; 2013 Mar; 10(3):1080-91. PubMed ID: 23320642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Core-shell structured gel-nanocarriers for sustained drug release and enhanced antitumor effect.
    He W; Lv Y; Zhao Y; Xu C; Jin Z; Qin C; Yin L
    Int J Pharm; 2015 Apr; 484(1-2):163-71. PubMed ID: 25724136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment.
    Yu D; Li W; Zhang Y; Zhang B
    Biomed Pharmacother; 2016 Oct; 83():1428-1435. PubMed ID: 27592131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.
    He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L
    Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sustained release of PTX-incorporated nanoparticles synergized by burst release of DOX⋅HCl from thermosensitive modified PEG/PCL hydrogel to improve anti-tumor efficiency.
    Xu S; Wang W; Li X; Liu J; Dong A; Deng L
    Eur J Pharm Sci; 2014 Oct; 62():267-73. PubMed ID: 24931190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PEGylation of paclitaxel largely improves its safety and anti-tumor efficacy following pulmonary delivery in a mouse model of lung carcinoma.
    Luo T; Loira-Pastoriza C; Patil HP; Ucakar B; Muccioli GG; Bosquillon C; Vanbever R
    J Control Release; 2016 Oct; 239():62-71. PubMed ID: 27515664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
    He M; Zhao Z; Yin L; Tang C; Yin C
    Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.